相互作用
Capecitabine + Idecabtagene vicleucel
重症度: 重大
Capecitabine and Idecabtagene vicleucel: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Capecitabine causes myelosuppression and lymphopenia, which can add to the prolonged cytopenias and infection risk seen after CAR-T therapy. Chemotherapy given around the time of cell infusion may also impair CAR-T expansion and persistence.
この相互作用をわかりやすく説明すると
Capecitabine and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Capecitabine belongs to Oncology; Idecabtagene vicleucel belongs to Oncology.
なぜ起こるのか
Additive myelosuppressive and immunosuppressive effects, with possible cytotoxic effects on infused T cells.
対処法
Avoid capecitabine during lymphodepletion and the early period after CAR-T infusion unless clearly required. If used, monitor blood counts and infection signs closely and give anti-infective prophylaxis as per protocol.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、CapecitabineとIdecabtagene vicleucelの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Capecitabineのその他の相互作用
Idecabtagene vicleucelのその他の相互作用
よくある質問
Can I take Capecitabine with Idecabtagene vicleucel?
MediHelp rates the interaction as major. Capecitabine and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Capecitabine causes myelosuppression and lymphopenia, which can add to the prolonged cytopenias and infection risk seen after CAR-T therapy. Chemotherapy given around the time of cell infusion may also impair CAR-T expansion and persistence.
How serious is the interaction between Capecitabine and Idecabtagene vicleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid capecitabine during lymphodepletion and the early period after CAR-T infusion unless clearly required. If used, monitor blood counts and infection signs closely and give anti-infective prophylaxis as per protocol.
What other medicines interact with Capecitabine?
MediHelp also lists interactions of Capecitabine with, for example, Adenovirus types 4 and 7 live, Arsenic trioxide, Axicabtagene ciloleucel. The full list is on the Capecitabine page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
